Compass Therapeutics, Inc.
CMPX· Nasdaq
Compass Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · -5.27%
- Market cap
- $153.89M
- 180.09M shares
- Filings
- 359
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $55,969,000 | reported | |
| FY 2024 | 2024-12-31 | $42,342,000 | reported | |
| FY 2023 | 2023-12-31 | $38,120,000 | reported | |
| FY 2022 | 2022-12-31 | $29,997,000 | reported | |
| FY 2021 | 2021-12-31 | $20,337,000 | reported | |
| FY 2020 | 2020-12-31 | $14,904,000 | reported | |
| FY 2019 | 2019-12-31 | $22,449,000 | reported |
Compass Therapeutics, Inc. · CIK 1738021 · Engraved from SEC EDGAR
